Naturland Holding PLC Logo

Naturland Holding PLC

A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.

NATUR | BUD

Overview

Corporate Details

ISIN(s):
HU0000199740
LEI:
Country:
United Kingdom
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Naturland Holding PLC is a Hungarian company engaged in the full scale of pharmaceutical manufacturing. Its activities encompass research and development, product licensing, production, and sales of pharmaceutical products. The company operates through its subsidiaries to develop and bring its products to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 12:04
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB
2025-09-30 12:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.3 KB
2025-09-25 17:34
Interim Report
Féléves jelentés
Hungarian 4.7 MB
2025-09-01 14:33
Declaration of Voting Results & Voting Rights Announcements
Szavazati jogok, alaptőke
Hungarian 148.4 KB

Automate Your Workflow. Get a real-time feed of all Naturland Holding PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Naturland Holding PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Naturland Holding PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.